Navigation Links
Digirad Corporation Reports Financial Results for First-Quarter 2008
Date:4/24/2008

s $1.4 million, or $(0.07) per share,

compared to net profit of $74,000, or $0.00 per share, in first-quarter

2007.

The Company's plan to stabilize growth of services revenues and reduce the effects of the economy and other market pressures includes not only continuing to drive the centers of influence strategy to augment direct sales and marketing to physicians but also a broader range of imaging services and, therefore, revenue sources. During first quarter Digirad began a pilot program to evaluate a new diagnostic ultrasound procedure to complement its current imaging services.

Physicians enrolled with DIS who are participating in the pilot program are finding that additional vascular imaging can enhance patient care. All primary-care physicians using DIS ultrasound services may soon be able to offer this new service to their patients.

Casner stated: "We will continue to pilot this program during the next few quarters and, if indications remain positive, anticipate rolling out this new service to the larger number of our DIS physicians who lease our ultrasound imaging services. Due to the way the new procedure easily fits into our current process, we would also be able to leverage our existing ultrasound infrastructure."

Other First-Quarter 2008 Updates:

-- DIS fleet upgrades: seven multi-head Cardius XPO cameras were added to

Digirad's mobile imaging services fleet during the quarter; 82 percent

of DIS' mobile fleet, or 68 systems, have been upgraded. The upgrades

of the entire fleet are expected to be completed during second-quarter

2008.

-- Asset utilization was 64 percent of 143 systems (nuclear and

ultrasound), compared to 58 percent of 82 systems (all nuclear) for

first-quarter 2007.

-- Cash and equivalents and securities available for sale on

March 31, 2008, totaled $26.4 million, compared to $31.7 million on

Decemb
'/>"/>

SOURCE Digirad Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Digirad Corporation to Release First Quarter Financial Results on April 24, 2008
2. Digirad Corporation Appoints John W. Sayward to Its Board of Directors
3. Digirad Corporation to Release Fourth Quarter, Year-End Financial Results on February 7, 2008
4. Digirad to Introduce New Clinical Standard for Cardiac SPECT
5. Digirad Corporation Board of Directors Appoints R. King Nelson Chairman
6. Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement
7. Digirad Reports 2007 Third-Quarter, Nine-Month Financial Results
8. Digirad Corporation Named to Deloitte Technology Fast 50
9. Digirad Corporation to Release Third Quarter, Nine-Month Financial Results on October 25, 2007
10. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
11. STERIS Corporation Declares Regular Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... ... 100% of all acids, chemicals and impurities; it also properly mineralizes the water ... it contains harmful contaminants.  These harmful contaminants are a byproduct of how the ...
(Date:7/6/2015)... ... July 06, 2015 , ... In ... medicine, the American Orthopaedic Society for Sports Medicine ( AOSSM ) will present ... Orlando, FL. As a leader in orthopaedic sports medicine, AOSSM annually provides ...
(Date:7/6/2015)... ... 06, 2015 , ... Acara Partners, a leading business team ... its complimentary educational webinar series for the summer of 2015. ... their clients through targeted marketing, sales, digital communications, branding and business development programs. ...
(Date:7/6/2015)... ... ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value of more ... of over 3.2 percent in the years to come to hit the USD 6.9 ... an anticipated launch of a number of promising pipeline candidates and an increase in ...
(Date:7/6/2015)... ... ... doTERRA, the leading global essential oils company, is pleased to announce the ... position as Director of the Hinckley Institute at the University of Utah, a position ... states that he was ready for a new challenge, and out of many potential ...
Breaking Medicine News(10 mins):Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4
... CHICAGO, July 8 The Hispanic ... its 75 city tour, including the top 10,Hispanic cities, to ... The tour recently cruised through Chicago hosting free,events to encourage ... well,with nature,s wellness drink: milk. , ...
... ... Can Promote Prostate Health , ... Jacksonville, Fla. (Vocus) July 8, 2009 -- On June 30th, the ... effectiveness" research. Among the 100 different questions posed, high on the list was ...
... , WEDNESDAY, July 8 (HealthDay News) -- Though researchers aren,t ... longer, they hope a drug used to prevent rejection of ... , Middle-age mice that were given the drug rapamycin (Sirolimus) ... didn,t get the drug. , The findings, disclosed in a ...
... , WASHINGTON and EVANSTON, Ill., July 8 ... a data integration partnership facilitating integration of a ... SimCapture(R). SimCapture is an all-in-one solution for capturing, ... encounters. Mentice, manufacturer of the Mentice VIST(TM) endovascular ...
... patients rely on drugs to prevent graft rejection, ... The class of immunosuppressive drugs known as calcineurin ... patients, kidneys and lead to high blood pressure, ... can effectively replace calcineurin inhibitors in preventing graft ...
... SAN FRANCISCO, July 8 For the third ... one of the top medical groups in California as measured ... is the nation,s largest professional organization of physician groups practicing ... as being one of the best medical groups in California ...
Cached Medicine News:Health News:The Hispanic got milk? Campaign Visits Chicago from July 2 - July 10 2Health News:'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer 2Health News:'Easter Island' Drug Adds Years to Mice 2Health News:B-Line Medical(R) and Mentice, Inc. Announce Data Integration Partnership 2Health News:B-Line Medical(R) and Mentice, Inc. Announce Data Integration Partnership 3Health News:Post-transplant combo can replace toxic immune-suppressing drugs in monkeys 2
(Date:7/6/2015)... 2015  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS ... announced the appointment of Joann V. Lofgren ... Market Development, effective July 6, 2015. In this role, ... executing on the company,s market and product development strategy ... to welcome Joann to the OncoSec team and have ...
(Date:7/5/2015)... TOKYO , July 6, 2015 ... first international symposium on Medical-Engineering Collaboration "Medicine ... on July 10, 2015 in Tokyo, ... or its medical applied research will present their ... technology and a new industry produced with 8K ...
(Date:7/4/2015)... Adding SIR-Spheres® Y-90 resin ... metastatic colorectal cancer in the liver (mCRC) further ... Patients with unresectable metastatic colorectal cancer (mCRC) that ... greatest improvement in Progression-Free Survival (PFS) in the ... microspheres to a current first-line chemotherapy regimen, according ...
Breaking Medicine Technology:OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... MATEO, Calif., Feb. 28, 2011 Nile Therapeutics, Inc. ... the development of novel therapeutics for heart failure patients, ... MDT ) on the clinical development of ... failure and renal disease applications. "We are ...
... 2011 Hotspur Technologies announced today that Dr. ... clinical use of its Keeper™ Embolectomy Catheter.  The ... within arteries, while also incorporating the capability of ... The Keeper Catheter combines a compliant ...
Cached Medicine Technology:Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease 2Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease 3Hotspur's Keeper Embolectomy Catheter Deployed for First Time 2
Round solid 15 mm wide lower plate. Open upper plate with inside diameter 12 mm. Serrated handle with locking thumb screw and polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
The popular E2002 Utrata Capsulorhexis Forceps with fine angled sharp tips. Angled 12 mm shafts with an iris stop. Flat handle with dull finish....
Fine angled tips ideal for grasping delicate capsule. Angled 12 mm shafts with iris stop allows ease of movement in the anterior chamber. Flat handle with dull finish. Manufactured in titanium....
Medicine Products: